eccogene glp-1 AstraZeneca's elecoglipron just posted some of the most closely watched Phase IIb data of the year and it landed at the right conference. Results from the VISTA and SOLSTICE trials, published simultaneously AstraZeneca raises stakes in obesity

Reflux, nausea, or abdominal symptoms that worsen after dose escalation and do not improve with basic plan changes

DEBUNKING THE BEYONCE SKIN BLEACHING MYTH: THE TRUTH ABOUT BLONDE HAIR & SKIN TONE In the world of celebrity culture, misconceptions can quickly take root, especially when it comes to iconic figures like Beyonc

Policy A caffeine overdose happens when you consume too much caffeine and it makes you sick

HUBERMAN: Incidentally, there are also Kispeptin antagonists, okay

There is one small pilot study in humans (examining knee pain, where 7 of 12 participants reported sustained improvement beyond 6 months) and a 2025 safety study confirming BPC-157 was well tolerated in healthy adults

Louis, United States Updates Copyright 2023 Mazzieri, Basta, Calafiore and Luca